 |
PDBsum entry 2qnq
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structure-Guided design of c2-Symmetric HIV-1 protease inhibitors based on a pyrrolidine scaffold.
|
 |
|
Authors
|
 |
A.Blum,
J.Böttcher,
A.Heine,
G.Klebe,
W.E.Diederich.
|
 |
|
Ref.
|
 |
J Med Chem, 2008,
51,
2078-2087.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Infections with the human immunodeficiency virus, which inevitably lead to the
development of AIDS, are still among the most serious global health problems
causing more than 2.5 million deaths per year. In the pathophysiological
processes of this pandemic, HIV protease has proven to be an invaluable drug
target because of its essential role in the virus' replication process. By use
of pyrrolidine as core structure, symmetric 3,4-bis-N-alkylsulfonamides were
designed and synthesized enantioselectively from D-(-)-tartaric acid as a new
class of HIV protease inhibitors. Structure-guided design using the cocrystal
structure of an initial lead as starting point resulted in a second series of
inhibitors with improved affinity. The binding modes of four representatives
were determined by X-ray crystallography to elucidate the underlying factors
accounting for the SAR. With this information for further rational design, the
combination of suitable side chains resulted in a final inhibitor showing a
significantly improved affinity of K(i) = 74 nM.
|
 |
|
|
|
|
 |